Oncotarget

Intraventricular Immunovirotherapy; A Translational Step Forward

Jan 26, 2023
Researchers Joshua D. Bernstock, Sarah Blitz, Kyung-Don Kang, and Gregory K. Friedman discuss Intraventricular Immunovirotherapy in cancer treatment using engineered type 1 herpes simplex virus. They highlight its efficacy in recent clinical trials for high-grade glioma and potential for targeting intractable diseases like disseminated medulloblastoma. The importance of Intraventricular Administration for targeted immunovirotherapy is emphasized.
Ask episode
Chapters
Transcript
Episode notes